A Double Blind, Randomized Trial of Alirocumab and Plaque Regression in Peripheral Artery Disease

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/176/30/21

Funding

  • University of Virginia (GI18433.155310)
  • Regeneron Pharmaceuticals, Inc. (GI18433.155310)